Search results

From WikiAnesthesia
  • Fentanyl (category Opioid analgesics)
    intranasal, intrathecal, epidural, buccal. µ-selective opioid receptor Low affinity: delta & kappa opioid receptors Context Sensitive Half Time Infusion or
    3 KB (110 words) - 19:31, 1 February 2023
  • mu-opioid receptor agonist and kappa-opioid receptor. It is unique in that its action at the mu-opioid receptor can block binding of other opioids. Methadone
    10 KB (1,127 words) - 20:50, 21 January 2023
  • Consider continuing buprenorphine/methadone therapy For patients on opioid agonist therapy with buprenorphine or methadone, consider continuing home dosing
    8 KB (906 words) - 11:34, 19 August 2023
  • observed with Precedex when used in combination. Fentanyl is a mu-opioid receptor agonist which may nonspecifically reduce emergence delirium by treating
    9 KB (949 words) - 18:45, 30 August 2022
  • (Redirects: Bloxiverz) Physostigmine Redirects: Alpha agonists, Alpha antagonists, Beta agonists Alpha-1 agonists Ephedrine Epinephrine (Redirects: Adrenaline)
    48 KB (3,882 words) - 14:34, 16 August 2023
  • File:Opioids and Cancer Recurrence Review (Cata 2016).pdf
    Brief review of opioids and cancer recurrence
    (1,275 × 1,650 (779 KB)) - 00:30, 17 May 2022
  • laxation response with methylnaltrexone treatment in cancer patients with opioid-induced constipation: The impact of baseline ECOG status". Journal of Clinical
    7 KB (615 words) - 18:31, 10 January 2024
  • sedation without respiratory depression or amnestic properties. May decrease opioid requirement, more so due to sedating rather than analgesic effects. Should
    3 KB (151 words) - 08:41, 9 August 2022
  • File:NMCP Anesthesiology Introductory Guide (rotator manual) Booklet Print.pdf (matches file content)
    Synthetic µ‐opioid agonist Synthetic µ‐opioid agonist µ‐opioid agonist NMDA receptor antagonist NSAID Selective cyclooxygenase inhibitor Direct α2 agonist Weak
    (1,650 × 1,275 (2.25 MB)) - 07:31, 29 August 2023
  • File:NMCP Anesthesiology Introductory Guide (rotator manual).pdf (matches file content)
    Synthetic µ-opioid agonist Synthetic µ-opioid agonist µ-opioid agonist NMDA receptor antagonist NSAID Selective cyclooxygenase inhibitor Direct α2 agonist Weak
    (825 × 1,275 (1.49 MB)) - 07:39, 29 August 2023
  • Naltrexone (antagonist) Buprenorphine (partial agonist) Molecular structure of anilidopiperidine opioids Alfentanil Fentanyl Remifentanil Sufentanil Molecular
    2 KB (80 words) - 09:16, 29 January 2023
  • File:The future of nonoperating room anesthesia in the 21st century emphasis on quality and safety.pdf (matches file content)
    produces significant analgesia with less tolerance. Kappa opioid agonists is another group of opioid analogs under development that show promise in providing
    (1,222 × 1,629 (545 KB)) - 00:38, 17 May 2022
  • lessening the burden of general anesthetics and systemic analgesics such as opioids. If the duration of post operative pain is expected to be less than or equal
    12 KB (1,542 words) - 12:01, 16 September 2023
  • contribute to differences in opioid requirements, potential of ADRs, and drug metabolism. Perception of pain, and thus opioid demand in the peri- and post-operative
    18 KB (2,664 words) - 19:49, 4 October 2022
  • 1, dose 320 mg) Alpha-agonists and beta-antagonists may worsen the Brugada ECG pattern, while alpha-antagonists and beta-agonists may improve it Case reports
    19 KB (2,301 words) - 23:40, 11 November 2022

View (previous 20 | next 20) (20 | 50 | 100 | 250 | 500)